Celldex to Report Second Quarter 2018 Financial Results and Host Corporate Update Call
The conference call and presentation will be webcast live over the Internet and can be accessed by going to the "Events & Presentations" page under the "Investors & Media" section of the
A replay of the call will be available approximately two hours after the live call concludes through
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline includes immunotherapies and other targeted biologics derived from a broad set of complementary technologies which have the ability to engage the human immune system and/or directly inhibit tumors to treat specific types of cancer or other diseases. Visit www.celldex.com.
Senior Vice President, Corporate Affairs & Administration
Source: Celldex Therapeutics, Inc.